Tomato is designed to have biological effects on consumers – but there's no safety data or GMO labelling

A gene-edited tomato that is intended to have a biological effect on consumers has been approved in Japan for commercial sale – without safety checks or GMO labelling. The tomato is genetically engineered to contain higher than usual amounts of GABA, a substance that is said to have the ability to lower blood pressure.